Altered processing of pro-orphanin FQ/nociceptin and pro-opiomelanocortin-derived peptides in the brains of mice expressing defective prohormone convertase 2
Rg. Allen et al., Altered processing of pro-orphanin FQ/nociceptin and pro-opiomelanocortin-derived peptides in the brains of mice expressing defective prohormone convertase 2, J NEUROSC, 21(16), 2001, pp. 5864-5870
The bioactivity of neuropeptides can be regulated by a variety of post-tran
slational modifications, including proteolytic processing. Here, gene-targe
ted mice producing defective prohormone convertase 2 (PC2) were used to exa
mine the post-translational processing of two neuroendocrine prohormones, p
ro-opiomelanocortin (POMC) and pro-orphanin FQ (pOFQ)/nociceptin (N), in th
e brain. Reversed-phase HPLC and gel-exclusion chromatography were combined
with specific radioimmunoassays to analyze the processing patterns of thes
e two prohormones in the hypothalamus and the amygdala. In the case of POMC
, the lack of PC2 activity completely prevented carboxy-shortening of beta
-endorphins and greatly diminished conversion of beta -lipotropin to gamma
-lipotropin and beta -endorphin. Although conversion of beta -lipotropin to
beta -endorphin decreased, the lack of PC2 activity caused an increase in
beta -lipotropin and beta -endorphin levels in the mutant animals, but no i
ncreases in POMC or biosynthetic intermediates were seen. The extent of OFQ
/N production was significantly lower in PC2-deficient mice and there was a
n accumulation of relatively large amounts of pOFQ/N and biosynthetic inter
mediates. These results demonstrate that PC2 is directly involved in the bi
ogenesis of two brain neuropeptides in vivo and suggest that the specific p
ro-hormone and cellular context influences neuropeptide processing by PCs.